Progesterone inhibits the migration and invasion of A549 lung cancer cells through membrane progesterone receptor α-mediated mechanisms

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1873-1880

  Xie, Mingxuan ^a   You, Shaojin ^b   Chen, Qiong ^a   Chen, Xi ^a   Hu, Chengping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Invasion; Lung cancer; Membrane progesterone receptor ; Migration; Progesterone

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE B; MEMBRANE PROGESTERONE RECEPTOR ALPHA; PROGESTERONE; PYRAZOLOPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; LUNG CANCER; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; DOWN-REGULATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROGESTERONE; RECEPTORS, PROGESTERONE;

EID: 84876248056     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2336     Document Type: Article

References (48)

1. Yang M and Pyo MY: Molecular epidemiology of lung cancer in female passive smokers. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 23: 75-97, 2005. (Pubitemid 40524494)
2. Stabile LP, Davis AL, Gubish CT, et al: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 62: 2141-2150, 2002. (Pubitemid 34408463)
3. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996. (Pubitemid 26190778)
4. Clarke CL and Sutherland RL: Progestin regulation of cellular proliferation. Endocr Rev 11: 266-301, 1990. (Pubitemid 20182871)
5. Lee WS, Harder JA, Yoshizumi M, Lee ME and Haber E: Progesterone inhibits arterial smooth muscle cell proliferation. Nat Med 3: 1005-1008, 1997. (Pubitemid 27391955)
6. Groshong SD, Owen GI, Grimison B, et al: Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11: 1593-1607, 1997. (Pubitemid 27435408)
7. Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R and Sutherland RL: Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. J Biol Chem 276: 47675-47683, 2001.
8. Santen RJ, Manni A, Harvey H and Redmond C: Endocrine treatment of breast cancer in women. Endocr Rev 11: 221-265, 1990. (Pubitemid 20182870)
9. Thigpen JT, Brady MF, Alvarez RD, et al: Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17: 1736-1744, 1999. (Pubitemid 29269242)
10. Lee YT: Better prognosis of many cancers in female: a phenomenon not explained by study of steroid receptors. J Surg Oncol 25: 255-262, 1984.
11. Su JM, Hsu HK, Chang H, et al: Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Anticancer Res 16: 3803-3806, 1996. (Pubitemid 27085052)
12. Check JH, Sansoucie L, Chern J and Dix E: Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer. Anticancer Res 30: 119-122, 2010.
13. Marquez-Garban DC, Mah V, Alavi M, et al: Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids 76: 910-920, 2011.
14. Tiutiunova AM, Chirvina ED, Mironenko TV, Kartashov SZ and Luntovskaia VA: Hormonal balance in women with lung cancer and its changes after combined treatment. Vopr Onkol 32: 26-30, 1986 (In Russian).
15. Zhu Y, Rice CD, Pang Y, Pace M and Thomas P: Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100: 2231-2236, 2003. (Pubitemid 36297482)
16. Zhu Y, Bond J and Thomas P: Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100: 2237-2242, 2003. (Pubitemid 36297483)
17. Thomas P: Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 29: 292-312, 2008.
18. Zuo L, Li W and You S: Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Res 12: R34, 2010.
19. Dosiou C, Hamilton AE, Pang Y, et al: Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 196: 67-77, 2008. (Pubitemid 351234572)
20. Ciavatta VT, Kim M, Wong P, et al: Retinal expression of Fgf2 in RCS rats with subretinal microphotodiode array. Invest Ophthalmol Vis Sci 50: 4523-4530, 2009.
21. Dhanesuan N, Sharp JA, Blick T, Price JT and Thompson EW: Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. Breast Cancer Res Treat 75: 73-85, 2002.
22. Desai B, Ma T and Chellaiah MA: Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. J Biol Chem 283: 13856-13866, 2008.
23. Beattie CW, Hansen NW and Thomas PA: Steroid receptors in human lung cancer. Cancer Res 45: 4206-4214, 1985. (Pubitemid 16224875)
24. Wu CT, Chang YL, Shih JY and Lee YC: The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 130: 979-986, 2005.
25. Fasco MJ, Hurteau GJ and Spivack SD: Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 188: 125-140, 2002. (Pubitemid 34242672)
26. Kaiser U, Hofmann J, Schilli M, et al: Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 67: 357-364, 1996. (Pubitemid 26274126)
27. Thomas P, Pang Y, Dong J, et al: Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology 148: 705-718, 2007. (Pubitemid 46143172)
28. Pang Y and Thomas P: Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor. Steroids 76: 921-928, 2011.
29. Krietsch T, Fernandes MS, Kero J, et al: Human homologs of the putative G protein-coupled membrane progestin receptors (mPRalpha, beta, and gamma) localize to the endoplasmic reticulum and are not activated by progesterone. Mol Endocrinol 20: 3146-3164, 2006. (Pubitemid 44833562)
30. Foster H, Reynolds A, Stenbeck G, Dong J, Thomas P and Karteris E: Internalisation of membrane progesterone receptor-alpha after treatment with progesterone: Potential involvement of a clathrin-dependent pathway. Mol Med Rep 3: 27-35, 2010.
31. Schafer C, Born S, Mohl C, et al: The key feature for early migratory processes: dependence of adhesion, actin bundles, force generation and transmission on filopodia. Cell Adh Migr 4: 215-225, 2010.
32. Ishibashi H, Suzuki T, Suzuki S, et al: Progesterone receptor in non-small cell lung cancer - a potent prognostic factor and possible target for endocrine therapy. Cancer Res 65: 6450-6458, 2005. (Pubitemid 40994434)
33. Zhu Y, Hanna RN, Schaaf MJ, Spaink HP and Thomas P: Candidates for membrane progestin receptors - past approaches and future challenges. Comp Biochem Physiol C Toxicol Pharmacol 148: 381-389, 2008.
34. Losel RM, Besong D, Peluso JJ and Wehling M: Progesterone receptor membrane component 1 - many tasks for a versatile protein. Steroids 73: 929-934, 2008.
35. Guarino M: Src signaling in cancer invasion. J Cell Physiol 223: 14-26, 2010.
36. Hanke JH, Gardner JP, Dow RL, et al: Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271: 695-701, 1996.
37. Karni R, Mizrachi S, Reiss-Sklan E, Gazit A, Livnah O and Levitzki A: The pp60c-Src inhibitor PP1 is non-competitive against ATP. FEBS Lett 537: 47-52, 2003. (Pubitemid 36246674)
38. Finn RS, Bengala C, Ibrahim N, et al: Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study. Clin Cancer Res 17: 6905-6913, 2011.
39. Tryfonopoulos D, Walsh S, Collins DM, et al: Src: a potential target for the treatment of triple-negative breast cancer. Ann Oncol 22: 2234-2240, 2011.
40. Mitra SK, Hanson DA and Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68, 2005. (Pubitemid 40064899)
41. Owens LV, Xu L, Craven RJ, et al: Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55: 2752-2755, 1995.
42. Siesser PM and Hanks SK: The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12: 3233-3237, 2006.
43. Hsu SP, Chen TH, Chou YP, et al: Extra-nuclear activation of progesterone receptor in regulating arterial smooth muscle cell migration. Atherosclerosis 217: 83-89, 2011.
44. Herbst RS, Yano S, Kuniyasu H, et al: Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 6: 790-797, 2000. (Pubitemid 30159331)
45. Martinella-Catusse C, Nawrocki B, Gilles C, Birembaut P and Polette M: Matrix-metalloproteinases in bronchopulmonary carcinomas. Histol Histopathol 14: 839-843, 1999.
46. Aleshin A and Finn RS: SRC: a century of science brought to the clinic. Neoplasia 12: 599-607, 2010.
47. Hung WC, Tseng WL, Shiea J and Chang HC: Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett 288: 156-161, 2010.
48. Xu XM, Zhang Y, Qu D, Feng XW, Chen Y and Zhao L: Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Mol Med Report 6: 1018-1022, 2012.